OPTOMETRIC SEMINAR
The New Wave of Ophthalmic Therapeutics: What Every Clinician Must Know Now
SEMINAR FEATURES
- Date
- July 31 - Aug 10, 2026
- Credits
- 12 CE
Course Fees
- Registration
- $895
- Opticians
- $595
- Staff
- $145
- GROUPS: Please call
*Discounted fee based upon purchase of vacation package. If purchased separately, please add $400 to the above fees.
ABOUT THE SEMINAR
This high-impact, fast-paced 12-hour CE program is designed for clinicians who want practical, real-world strategies—not theory. The focus is on modern diagnosis, emerging therapies, and confident decision-making in everyday patient care.
Walk away knowing exactly what to treat, what to watch, and what you can’t afford to miss in today’s rapidly evolving eye care landscape.
You will take home clinical pearls that can be used immediately upon the conclusion of this seminar.
Course Content
- Red Eye Gone Wrong: Viral Eye Disease, Masqueraders, and What You Can’t Afford to Miss
- Glaucoma’s Next Move: Deep Dive
- The New Wave of Ophthalmic Therapeutics: Translating Innovation into Clinical Practice
- Headache Red Flags in Eye Care: Neuro-Ophthalmic Clues You Can’t Afford to Miss
- Optic Neuropathy Red Flags: Diagnosing Vision-Threatening Disease Before It’s Too Late
- Ocular Emergencies & Trauma: Rapid Decision-Making
Learning Objectives
- Apply modern treatment strategies for ocular disease
- Integrate new therapies into clinical care
- Learn how to recognize vision-threatening disease earlier
- Recognize high-risk conditions requiring urgent referral
- Avoid common diagnostic pitfalls
- Improve efficiency and accuracy in decision-making
- Gain clarity on when to treat vs when to refer
- Cut through the overload of new drugs and focus on what actually works
- Deliver better patient outcomes through practical application
ABOUT THE INSTRUCTOR
Dr. Ron Melton is an internationally recognized leader in ocular disease and medical optometry, known for delivering high-yield, clinically relevant education that directly impacts patient care. He has presented more than 1,000 continuing education lectures worldwide and is widely respected for his ability to translate complex topics into practical, real-world clinical decision-making.
He has authored or co-authored over 100 publications and is best known as co-author of the Clinical Guide to Ophthalmic Drugs, a cornerstone resource in clinical optometry for over 25 years. He serves on the editorial advisory board for Review of Optometry.
Dr. Melton is a Diplomate of the American Board of Optometry and has participated in more than 60 clinical research trials. He is on the adjunct faculty at both the Indiana University School of Optometry and the Pennsylvania College of Optometry at Drexel University.
His honors include the 2024 Golden ICARE Award, recognition among Newsweek’s America’s Best Optometrists (2021–2023), and the American Academy of Optometry’s Vincent Ellerbrock Clinician Educator Award.
He practices in Charlotte, North Carolina, and holds hospital privileges at Novant Health Presbyterian Medical Center.
